Avanos Medical Inc. Stock News

In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical (AVNS), with a price target of $29.00. The

In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical ( AVNS – Research Report ), with a price target of $29.00 . The company’s shares closed last

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Blueshift Asset Management LLC purchased a new position in shares of Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Citigroup Inc. increased its position in shares of Avanos Medical Inc (NYSE:AVNS) by 208.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &

Great West Life Assurance Co. Can acquired a new position in Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and E

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Prudential Financial Inc. grew its stake in Avanos Medical Inc (NYSE:AVNS) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional inv

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm

In 2017 Joe Woody was appointed CEO of Avanos Medical, Inc. (NYSE:AVNS). This report will, first, examine the CEO...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

NEW YORK, March 18, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc..

Avanos Medical Inc (NYSE:AVNS) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,230,000 shares, a gro